#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation - 2 Minute Medicine

1 year ago 50

2 Minute Medicine

2 Minute Medicine® is an grant winning, physician-run, adept aesculapian media company. Our contented is curated, written and edited by practicing wellness professionals who person objective and technological expertise successful their tract of reporting. Our editorial absorption squad is comprised of highly-trained MD physicians. Join galore brands, companies, and hospitals who spot our licensed content.

Read Entire Article